Honeybees Vaccine: The United States Department of Agriculture (USDA) has granted a conditional license for the vaccination of honeybees against American foulbrood disease, which is caused by Paenibacillus larvae. This news was announced today by Dalan Animal Health, Inc. (“Dalan”), a biotech company that was an early pioneer in the field of insect health.
Agriculture relies heavily on honeybees and other pollinators like them. Pollination is responsible for one-third of the world’s food supply, and having commercial beehives that are in good condition is crucial to ensuring enough crop harvests. Honeybees, on the other hand, are afflicted with American Foulbrood, and there has not been a method that is both secure and long-term for preventing the disease. In the United States of America and Canada, overt clinical cases of American Foulbrood are required to be reported, and the only treatment technique involves the destruction of bees along with diseased hives and other equipment.
Trevor Tauzer, the proprietor of Tauzer Apiaries and board member of the California State Beekeepers Association, described this development as “an exciting step forward for beekeepers.” “We rely on antibiotic treatment that has limited efficiency and needs lots of time and energy to apply to our hives,” Tauzer said. Those who raise bees will find this to be a very promising development. We can avoid spending a lot of money on treatment if we can prevent an illness from spreading in our hives, and we’ll have more time and resources to devote to maintaining the health of our bees.
We are committed to finding innovative ways to protect pollinators and promote sustainable farming practices. Both the growing human population and the shifting climate will increase the importance of honeybee pollination to the security of our food supply. The development of our Honeybees vaccine represents a major step forward in the fight to safeguard honeybees. According to Dr. Annette Kleiser, Chief Executive Officer of Dalan Animal Health, “We are poised to transform how we care for insects, which will affect food production on a global basis.”
The bacterin was initially created by Dalan Animal Health, but it is now produced by Diamond Animal Health in Des Moines, Iowa. Diamond Animal Health is a wholly-owned subsidiary of Heska (“Heska”; NASDAQ: HSKA), which is the parent company.
When asked about Diamond’s help with industrial development and regulatory expertise, Kleiser said, “We are happy for the guidance and assistance that Diamond has indeed been able to provide.” We appreciate Diamond not only for the help and backing it has given us but also for the help itself. In the initial occurrence, the conditional license was awarded by the USDA for a period of two years. The Honeybees vaccine will only be made available to a select group of commercial beekeepers through Dalan’s program, and the company anticipates making it commercially available in the United States in 2023.
Regarding the Honeybees Vaccine
The Honeybees vaccine, which is administered by mixing it with queen feed, which is ingested by worker bees, contains bacteria from Paenibacillus larvae that have been killed completely at the whole-cell level. The worker bees are the ones who combine the vaccine into the royal jelly, and then it is the worker bees who feed it to the queen. She swallows it, and subsequent imaging reveals that bits of the vaccination have been lodged in her ovary. Because they were given the vaccination when they were still larvae, the newly hatched insects are immune to the disease.
Honeybees can be given an oral Honeybees vaccine to lower the risk of American foulbrood, which is an infection caused by the parasite P. larvae. This strategy has been shown to be effective in pivotal effectiveness studies. The vaccine does not contain any genetically modified organisms and can be used in organic farming.
What You Need to Know About Dalan Animal Health, Inc. developer of Honeybees Vaccine
Dalan Animal Health (www.dalan.com) is committed to reducing the incidence of diseases that are transmitted by invertebrates in order to improve the overall profitability and output for producers all over the world. The platform technology used by the company makes use of a method known as transgenerational immune priming. In this method, the immune modulators that the maternal animal possesses (such as antigens or compounds that fight microbes) are passed on to the next generation of larvae before they hatch.
This strategy is going to be utilized by the company to create vaccinations for other diseases that affect honeybees as well as Honeybees vaccines for underserved industries such as the shrimp, mealworms, and agricultural insect markets. The Innovation Hub on the University of Georgia’s campus serves as the location of the company’s headquarters in Athens, Georgia.
The United States has approved the world’s first Honeybees Vaccine (Video) Watch Now
Can bees be vaccinated?
Scientists have now made a vaccine to prevent honeybees and other pollinators from getting American foulbrood disease. The disease is one of the most dangerous and common diseases that affect bee broods. They give vaccines to queen bees in the form of a sugar patty that releases 10–15 grams of vaccine over a week.